advisorsecurities master

CATXPerspective Therapeutics, Inc.

CSNYSE American, LLC (XASE)·USD

Identity

Security key
13125
Ticker
CATX
Type
CSCommon Stock
Exchange
NYSE American, LLC(XASE)
Venue group
NYSE
Operating MIC
XNYS
Market
stocks
Locale
us
Currency
USD
Listed
2003-12-29
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
CATX

Detail

Enriched 2026-08-14 20:47

Market cap
$372,134,421.38
Shares outstanding (class)
114,046,197
Shares outstanding (weighted)
114,151,663
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
166
Location
SEATTLE, WA
Description

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data